Skip to main content

Applying Artificial Intelligence in Pediatric Clinical Trials: Potential Impacts and Obstacles.

Publication ,  Journal Article
Foote, HP; Cohen-Wolkowiez, M; Lindsell, CJ; Hornik, CP
Published in: J Pediatr Pharmacol Ther
June 2024

Duke Scholars

Published In

J Pediatr Pharmacol Ther

DOI

ISSN

1551-6776

Publication Date

June 2024

Volume

29

Issue

3

Start / End Page

336 / 340

Location

United States

Related Subject Headings

  • 3214 Pharmacology and pharmaceutical sciences
  • 3213 Paediatrics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Foote, H. P., Cohen-Wolkowiez, M., Lindsell, C. J., & Hornik, C. P. (2024). Applying Artificial Intelligence in Pediatric Clinical Trials: Potential Impacts and Obstacles. J Pediatr Pharmacol Ther, 29(3), 336–340. https://doi.org/10.5863/1551-6776-29.3.336
Foote, Henry P., Michael Cohen-Wolkowiez, Christopher J. Lindsell, and Christoph P. Hornik. “Applying Artificial Intelligence in Pediatric Clinical Trials: Potential Impacts and Obstacles.J Pediatr Pharmacol Ther 29, no. 3 (June 2024): 336–40. https://doi.org/10.5863/1551-6776-29.3.336.
Foote HP, Cohen-Wolkowiez M, Lindsell CJ, Hornik CP. Applying Artificial Intelligence in Pediatric Clinical Trials: Potential Impacts and Obstacles. J Pediatr Pharmacol Ther. 2024 Jun;29(3):336–40.
Foote, Henry P., et al. “Applying Artificial Intelligence in Pediatric Clinical Trials: Potential Impacts and Obstacles.J Pediatr Pharmacol Ther, vol. 29, no. 3, June 2024, pp. 336–40. Pubmed, doi:10.5863/1551-6776-29.3.336.
Foote HP, Cohen-Wolkowiez M, Lindsell CJ, Hornik CP. Applying Artificial Intelligence in Pediatric Clinical Trials: Potential Impacts and Obstacles. J Pediatr Pharmacol Ther. 2024 Jun;29(3):336–340.

Published In

J Pediatr Pharmacol Ther

DOI

ISSN

1551-6776

Publication Date

June 2024

Volume

29

Issue

3

Start / End Page

336 / 340

Location

United States

Related Subject Headings

  • 3214 Pharmacology and pharmaceutical sciences
  • 3213 Paediatrics